MacLaren R - Search Results

1

Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients.

MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. MacLaren R, et al. JPEN J Parenter Enteral Nutr. 2008 Jul-Aug;32(4):412-9. doi: 10.1177/0148607108319803. JPEN J Parenter Enteral Nutr. 2008. PMID: 18596312 Clinical Trial.

2

Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.

MacLaren R, Kuhl DA, Gervasio JM, Brown RO, Dickerson RN, Livingston TN, Swift K, Headley S, Kudsk KA, Lima JJ. MacLaren R, et al. Crit Care Med. 2000 Feb;28(2):438-44. doi: 10.1097/00003246-200002000-00025. Crit Care Med. 2000. PMID: 10708180 Free article. Clinical Trial.

3

Intolerance to intragastric enteral nutrition in critically ill patients: complications and management.

MacLaren R. MacLaren R. Pharmacotherapy. 2000 Dec;20(12):1486-98. doi: 10.1592/phco.20.19.1486.34853. Pharmacotherapy. 2000. PMID: 11130221 Review.

4

Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults.

MacLaren R, Patrick WD, Hall RI, Rocker GM, Whelan GJ, Lima JJ. MacLaren R, et al. Clin Ther. 2001 Nov;23(11):1855-66. doi: 10.1016/s0149-2918(00)89081-5. Clin Ther. 2001. PMID: 11768837 Clinical Trial.

5

Use of enteral nutrition for stress ulcer prophylaxis.

MacLaren R, Jarvis CL, Fish DN. MacLaren R, et al. Ann Pharmacother. 2001 Dec;35(12):1614-23. doi: 10.1345/aph.1A083. Ann Pharmacother. 2001. PMID: 11793631 Review.

6

Use of exogenous erythropoietin in critically ill patients.

MacLaren R, Gasper J, Jung R, Vandivier RW. MacLaren R, et al. J Clin Pharm Ther. 2004 Jun;29(3):195-208. doi: 10.1111/j.1365-2710.2004.00552.x. J Clin Pharm Ther. 2004. PMID: 15153081 Review.

7

Effects of continuous vasopressin infusion in patients with septic shock.

Obritsch MD, Jung R, Fish DN, MacLaren R. Obritsch MD, et al. Among authors: maclaren r. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. doi: 10.1345/aph.1D513. Epub 2004 Jun 3. Ann Pharmacother. 2004. PMID: 15178740

8

Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.

Jung R, Fish DN, Obritsch MD, MacLaren R. Jung R, et al. Among authors: maclaren r. J Hosp Infect. 2004 Jun;57(2):105-11. doi: 10.1016/j.jhin.2004.03.001. J Hosp Infect. 2004. PMID: 15183239

9

The role of vasopressin in vasodilatory septic shock.

Obritsch MD, Bestul DJ, Jung R, Fish DN, MacLaren R. Obritsch MD, et al. Among authors: maclaren r. Pharmacotherapy. 2004 Aug;24(8):1050-63. doi: 10.1592/phco.24.11.1050.36144. Pharmacotherapy. 2004. PMID: 15338853 Review.

10

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

Obritsch MD, Fish DN, MacLaren R, Jung R. Obritsch MD, et al. Among authors: maclaren r. Antimicrob Agents Chemother. 2004 Dec;48(12):4606-10. doi: 10.1128/AAC.48.12.4606-4610.2004. Antimicrob Agents Chemother. 2004. PMID: 15561832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

588 results

Search Page

Filters